CANTOS Trial: Canakinumab Reduces MACE and Mortality Among CKD Patients Dr. Ridker and Dr. C. Michael Gibson By Tarek Nafee, M.D. on March 11, 2018 http://cardiologynownews.org/wp-content/uploads/2018/03/sun_1130_gibson_ridker.mp4
Leave a Reply
You must be logged in to post a comment.